Research Topics
Genomes and Genes
| Amita Shukla-DaveSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancerAmita Shukla-Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
BJU Int 109:1315-22. 2012..Upon initial testing, the new MR models performed significantly better than a clinical model lacking detailed biopsy data...
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesAmita Shukla-Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 82:1837-44. 2012..The goal of this study was to assess the prognostic value of pretreatment DCE-MRI in head and neck squamous cell carcinoma (HNSCC) patients with nodal disease undergoing chemoradiation therapy or surgery...
Imaging low-risk prostate cancerAmita Shukla-Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Curr Opin Urol 18:78-86. 2008..The review discusses the potential role of imaging in identifying low-risk prostate cancer and enabling more appropriate management of the disease...
Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyaminesAmita Shukla-Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021 USA
Radiology 245:499-506. 2007....
Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancerAmita Shukla-Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 250:803-12. 2009....
Average arterial input function for quantitative dynamic contrast enhanced magnetic resonance imaging of neck nodal metastasesAmita Shukla Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
BMC Med Phys 9:4. 2009..Further validation of the Avg-AIF approach with a larger population and in multiple regions is desirable...
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profilesAmita Shukla-Dave
Departments of Medical Physics, Memorial Sloan Kettering Cancer Center New York, New York, USA
Clin Cancer Res 15:3842-9. 2009....
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observationsAmita Shukla-Dave
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Radiology 231:717-24. 2004..To determine whether chronic prostatitis affects three-dimensional proton magnetic resonance (MR) spectroscopic imaging in evaluation of disease in the peripheral zone...
Loss of the tumor suppressor PML in human cancers of multiple histologic originsCarmela Gurrieri
Molecular Biology Program and Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Natl Cancer Inst 96:269-79. 2004..However, its role in the pathogenesis of human cancers other than APL is still unclear. We therefore assessed the status and expression of the PML gene in solid tumors of multiple histologic origins...
Loss of p63 expression is associated with tumor progression in bladder cancerMarshall J Urist
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 161:1199-206. 2002..These data indicate that in contrast to the skin and prostate, p63 is not required for formation of a bladder epithelium but is indispensable for the specific differentiation of a transitional urothelium...
Gene discovery in bladder cancer progression using cDNA microarraysMarta Sanchez-Carbayo
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Pathol 163:505-16. 2003..The present study has identified molecular biomarkers of potential clinical significance and critical molecular targets associated with bladder cancer progression...
p63 expression profiles in human normal and tumor tissuesCharles J Di Como
Division of Molecular Pathology, Department of Pathology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 8:494-501. 2002..The p63 gene, located on chromosome 3q27-28, is a member of the p53 gene family. The product encoded by the p63 gene has been reported to be essential for normal development...
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancerPere Puig
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 9:5642-51. 2003..To characterize the expression profile of p73 in human normal tissues by immunohistochemistry (IHC) and to analyze the correlation between p73 expression and bladder cancer progression...
Pten dose dictates cancer progression in the prostateLloyd C Trotman
Molecular Biology Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, New York, USA
PLoS Biol 1:E59. 2003..Our results provide conclusive genetic support for the notion that PTEN is haploinsufficient in tumor suppression and that its dose is a key determinant in cancer progression...
The TLX1 oncogene drives aneuploidy in T cell transformationKim De Keersmaecker
Institute for Cancer Genetics, Columbia University, New York, New York, USA
Nat Med 16:1321-7. 2010..These results identify a previously unrecognized mechanism contributing to chromosomal missegregation and aneuploidy active at the earliest stages of tumor development in the pathogenesis of cancer...
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PETJacobus F A Jansen
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Int J Radiat Oncol Biol Phys 82:299-307. 2012..Additionally, pretreatment multimodality imaging was evaluated for its efficacy in predicting short-term response to treatment...
Role of the proto-oncogene Pokemon in cellular transformation and ARF repressionTakahiro Maeda
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 433:278-85. 2005..Pokemon's critical role in cellular transformation makes it an attractive target for therapeutic intervention...
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomyKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Urol 184:2320-7. 2010..We determined whether pretreatment endorectal magnetic resonance imaging/magnetic resonance spectroscopic imaging predicts biochemical recurrence after radical prostatectomy...
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORRosa Bernardi
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 442:779-85. 2006..Thus, our findings identify PML as a novel suppressor of mTOR and neoangiogenesis...
Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypesMarta Sanchez-Carbayo
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 62:6973-80. 2002..However, it appears that deregulation of cell adhesion is a common event associated with tumor progression in uroepithelial neoplasms...
Hydrophilic agarose macrobead cultures select for outgrowth of carcinoma cell populations that can restrict tumor growthBarry H Smith
The Rogosin Institute, New York, New York 10021, USA
Cancer Res 71:725-35. 2011....
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic controlEva Hernando
Department of Pathology, Memorial Sloan Kettering Cancer Center New York, New York 10021, USA
Nature 430:797-802. 2004....
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysisAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Hum Pathol 34:54-64. 2003..The molecular phenotype, p27(+)Bcl-2(+)Ki-67(-)mdm2(+), appears to be unique to nonmalignant parathyroid tumors, and multimarker phenotypes are more complex in carcinomas...
Expression of p63 in diffuse large B-cell lymphomaCyrus V Hedvat
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Appl Immunohistochem Mol Morphol 13:237-42. 2005..Even though in univariate analysis p63 expression did not correlate with overall survival, the association of p63 with increased proliferative index suggests its involvement in DLBCL tumor progression...
HDM2 protein overexpression and prognosis in primary malignant melanomaDavid Polsky
Department of Dermatology, Medical Center, New York University School of Medicine, 550 1st Avenue, New York, NY 10016, USA
J Natl Cancer Inst 94:1803-6. 2002..33 to 0.94; two-sided chi(2) P =.027) in multivariable analysis. HDM2 overexpression appears to be an independent predictor of survival for patients with primary melanoma; however, larger prospective studies are required for validation...
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomasEva Hernando
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nat Med 13:748-53. 2007....
Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysisAxel Hoos
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 8:3841-9. 2002..However, down-regulation of p27 appears to be associated with a trend toward reduced DFS and DSS, which suggests further investigation of other p27-related pathways potentially relevant for metastatic disease...
Distinct expression profiles of p63 variants during urothelial development and bladder cancer progressionOrit Karni-Schmidt
Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York 10032, USA
Am J Pathol 178:1350-60. 2011..This study highlights the relevance of p63 isoforms in both urothelial development and bladder carcinoma progression, with ΔNp63 acting as an oncogene in certain invasive bladder tumors...
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemiaCarmela Gurrieri
Molecular Biology Program and Department of Pathology, Memorial Sloan Kettering Cancer Center, Sloan Kettering Division, Graduate School of Medical Sciences, Cornell University, New York, NY 10021, USA
Blood 103:2358-62. 2004..Complete functional loss of PML is therefore selected by the APL phenotype and associates with poor prognosis and RA unresponsiveness...
Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRIMichael H Fuchsjäger
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 78:743-50. 2010..To investigate whether pretreatment endorectal magnetic resonance imaging (MRI) findings can predict biochemical relapse in patients with clinically localized prostate cancer treated with external beam radiation therapy (EBRT)...
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial resultsKristen L Zakian
Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Radiology 229:241-7. 2003..To determine whether cancers of the prostate transition zone (TZ) possess a unique metabolic pattern by which they may be identified at proton magnetic resonance (MR) spectroscopic imaging...
Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic diseaseMichael J Donovan
Aureon Laboratories, Yonkers, New York, NY, USA
BJU Int 105:462-7. 2010....
Personalized prediction of tumor response and cancer progression on prostate needle biopsyMichael J Donovan
Aureon Laboratories, Inc, New York, New York 10701, USA
J Urol 182:125-32. 2009..We developed a patient specific, biology driven tool to predict outcome at diagnosis. We also investigated whether biopsy androgen receptor levels predict a durable response to therapy after secondary treatment...
Identification of a tumour suppressor network opposing nuclear Akt functionLloyd C Trotman
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 441:523-7. 2006..Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment...
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisZhenbang Chen
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, New York 10021, USA
Nature 436:725-30. 2005..Our results demonstrate the relevance of cellular senescence in restricting tumorigenesis in vivo and support a model for cooperative tumour suppression in which p53 is an essential failsafe protein of Pten-deficient tumours...
Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcomeMarta Sanchez-Carbayo
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 162:609-17. 2003..A potential tumor suppressor role in bladder cancer was revealed for KiSS-1. Moreover, it showed predictive value by identifying patients with poor outcome...
Ubiquitination regulates PTEN nuclear import and tumor suppressionLloyd C Trotman
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 128:141-56. 2007....
A multigenic program mediating breast cancer metastasis to boneYibin Kang
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer Cell 3:537-49. 2003....
ETS rearrangements and prostate cancer initiationBrett S Carver
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nature 457:E1; discussion E2-3. 2009..To this end, we demonstrate that the prostate-specific overexpression of ERG does not initiate prostate tumorigenesis...
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomyKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 234:804-14. 2005..To determine whether hydrogen 1 magnetic resonance (MR) spectroscopic imaging can be used to predict aggressiveness of prostate cancer...
Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findingsYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10021, USA
Radiology 246:480-8. 2008....
Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisitedMonica Garcia-Barros
Laboratory of Signal Transduction and Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center Department of Pathology, Columbia University, New York, NY 10065, USA
Cancer Res 70:8179-86. 2010....
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancerMichael J Morris
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Appl Immunohistochem Mol Morphol 13:6-13. 2005..These data support the dose selection of ongoing phase 2 studies of G3139 at 7 mg/kg/d and docetaxel 75 mg/m2...
Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatinEiji Kikuchi
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 10:1835-42. 2004..The purpose of this study was to investigate whether local overexpression of endostatin could serve to diminish tumor growth of bladder cancer in vivo...
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathwayIgor Matushansky
Department of Medicine, Columbia University, New York, New York 10032, USA
J Clin Invest 117:3248-57. 2007..Our results provide mechanistic insights regarding the cell of origin of MFH, establish what we believe is a novel tumor suppressor role for Wnt signaling, and identify a potential therapeutic differentiation strategy for sarcomas...
Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladderJin Cheng
Department of Urology, Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016, USA
Cancer Res 63:179-85. 2003..On the basis of our current and previous transgenic studies, we have proposed an integrated pathway progression model of bladder cancer...
Classification of clear-cell sarcoma as a subtype of melanoma by genomic profilingNeil H Segal
Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 21:1775-81. 2003..CCS/MSP also has typical melanoma features, including immunoreactivity for S100 and HMB45, pigmentation, MITF-M expression, and a propensity for regional lymph node metastases...
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patientsMarija Drobnjak
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Clin Cancer Res 9:2613-9. 2003..CONCLUSIONS: Our data suggest a role for Skp2 overexpression in prostate cancer pathogenesis that might not be exclusively related to p27 degradation. More studies are needed to determine the mechanistic role of Skp2 in prostate cancer...
Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppressionLi Ma
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 19:1779-86. 2005....
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysisAmita Shukla Dave
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
BJU Int 99:786-93. 2007..To design new models that combine clinical variables and biopsy data with magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) data, and assess their value in predicting the probability of insignificant prostate cancer...
Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancerMithat Gonen
Departments of Epidemiology and Biostatistics, Medicine, Surgery, and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 21:406-12. 2003....
A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancerMarta Sanchez-Carbayo
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 13:3215-20. 2007..In this study, we aim to evaluate the SNP309 in bladder cancer and to link it to TP53 status...
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective studyHebert Alberto Vargas
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10065, USA
Radiology 265:478-87. 2012....
Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imagingJingbo Zhang
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10065, USA
Radiology 253:425-34. 2009....
Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1)Yuhui Liu
Department of Molecular Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
EMBO J 26:4683-93. 2007..These genetic results suggest that p21 acts through the cyclin D1-cdk4 complex to support tumor growth, and establish the utility of using a somatic cell modeling system for defining the contribution proteins make to tumor development...
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancerLi Ma
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Res 67:7106-12. 2007..Importantly, our results indicate that Erk-mediated phosphorylation and inactivation of TSC2 can be critical in development of hamartomatous lesions in TSC and cancer pathogenesis...
A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomasIgor Matushansky
Department of Pathology, Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, New York, NY 10032, USA
Am J Pathol 172:1069-80. 2008..Our results indicate that a degree of developmental maturity can be quantitatively assigned to solid tumors, supporting the notion that transformation of a solid tumor stem cell can occur at distinct stages of maturation...
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceHui Kuan Lin
Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Nature 464:374-9. 2010..Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy...
Oncogenes in melanomaDavid Polsky
Department of Dermatology, New York University Medical Center, 550 First Avenue, New York, NY 10016, USA
Oncogene 22:3087-91. 2003..We provide a general overview of the mechanisms of oncogene activation and the functions of oncogenes. Lastly, we review oncogenic events in melanoma...
Role of Dok-1 and Dok-2 in leukemia suppressionMasaru Niki
Cancer Biology and Genetics Program and Dept of Pathology, Box 110, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Exp Med 200:1689-95. 2004..These findings unravel the critical and unexpected role of Dok-1 and Dok-2 in tumor suppression and control of the hematopoietic compartment homeostasis...
p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibitionSusana Gonzalez
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer Res 65:2186-92. 2005..In the clinical context, these results might have potential therapeutic implications, because p73beta could induce alternative apoptotic responses in tumors harboring p53 mutations...
p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor developmentCarmen Carneiro
Department of Molecular Biology, Menmorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Oncogene 22:361-9. 2003..From these studies, we concluded that the absence of p27 disabled the trigger for an Arf-dependent apoptotic response in Rb-/- tumor cells. This suggests a novel mechanism by which the loss of p27 may impact on tumor development...
Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomesManish A Shah
Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 11:3296-302. 2005..The clinical evaluation of Drg1 in colorectal cancer has been limited. We performed this study to evaluate the role of Drg1 in a large cohort of patients with metastatic colorectal cancer who were irinotecan naive...
Extension of the intravoxel incoherent motion model to non-gaussian diffusion in head and neck cancerYonggang Lu
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Magn Reson Imaging 36:1088-96. 2012..To extend the intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) model to restricted diffusion and to simultaneously quantify the perfusion and restricted diffusion parameters in neck nodal metastases...
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidenceDarko Pucar
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 69:62-9. 2007....
The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experienceCecilia Wassberg
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
AJR Am J Roentgenol 199:360-6. 2012....
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastasesJacobus F A Jansen
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 77:1403-10. 2010....
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTENXinjiang Wang
Cell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 522, New York, NY 10021, USA
Cell 128:129-39. 2007..Therefore, NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN via ubiquitination, a paradigm analogous to that of Mdm2 and p53...
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modificationDavide Ruggero
Molecular Biology Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, 1275 York Avenue, New York, NY 10021, USA
Science 299:259-62. 2003..These results suggest that deregulated ribosome function is important in the initiation of DC, whereas telomere shortening may modify and/or exacerbate DC...
Racial disparity of epidermal growth factor receptor expression in prostate cancerBrian Shuch
Department of Urology, New York University Cancer Institute, New York, NY, USA
J Clin Oncol 22:4725-9. 2004..CONCLUSION: Our data demonstrate that race contributes significantly to variability of EGFR expression in prostate cancer. Racial background may have an impact on the design of clinical trials to test the efficacy of anti-EGFR agents...
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemiaTeresa Palomero
Institute for Cancer Genetics, Columbia University, New York, New York 10032, USA
Nat Med 13:1203-10. 2007....
Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosaJimmy A Rotolo
Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 70:804-15. 2008..To address in vivo the issue of whether Bax and Bak are functionally redundant in signaling apoptosis, capable of substituting for each other...
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomasBhuvanesh Singh
Laboratory of Epithelial Cancer Biology, The Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 161:365-71. 2002..6; 95% confidence interval = 1.9 to 29.6). The findings suggest that the 3q copy number status is an important marker for tumor progression and prognostication in patients with head and neck squamous cell carcinoma...
Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysisJacobus F A Jansen
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Oral Oncol 48:717-22. 2012..Future studies with larger patient populations need to be carried out to validate and clarify our preliminary findings...
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancerHebert Alberto Vargas
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Electronic address
J Urol 188:1732-8. 2012..We assessed the value of endorectal magnetic resonance imaging in predicting upgrading on confirmatory biopsy in men with low risk prostate cancer...
Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volumeYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 278, New York, NY 10065, USA
Radiology 252:449-57. 2009....
Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experienceDarko Pucar
Department of Radiology, Medical Physics, Epidemiology and Biostatistics, Urology, Pathology, and Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 236:545-53. 2005..CONCLUSION: In summary, MR imaging and MR spectroscopy may be more sensitive than sextant biopsy and digital rectal examination for sextant localization of cancer recurrence after external-beam radiation therapy...
Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genesMarta Sanchez-Carbayo
Memorial Sloan-Kettering Cancer Center, Albert Einstein College of Medicine, York, New York 10021, USA
Lab Invest 83:507-17. 2003..This study further elucidates the genetic events associated with MDR1 expression and identifies novel targets associated with multidrug resistance...
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarraysMarta Sanchez-Carbayo
Division of Molecular Pathology and Computational Biology Center Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Oncol 24:778-89. 2006..Bladder cancer is a common malignancy characterized by a poor clinical outcome when tumors progress into invasive disease. We sought to define genetic signatures characteristic of aggressive clinical behavior in advanced bladder tumors...
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesisLan Mo
Department of Urology, New York University Cancer Institute, New York University School of Medicine, New York, New York, USA
J Clin Invest 117:314-25. 2007....
Inactivation of p53 and Pten promotes invasive bladder cancerAnna M Puzio-Kuter
Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA
Genes Dev 23:675-80. 2009..Our integrated analyses of mouse and human bladder cancer provide a rationale for investigating mTOR inhibition for treatment of patients with invasive disease...
Adrenocortical carcinoma: clinical, morphologic, and molecular characterizationAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 20:941-50. 2002..Multimolecular phenotyping demonstrates that the molecular complexity and heterogeneity of these neoplasms are such that targeted therapy needs to be patient specific...
Diffusion-weighted magnetic resonance imaging of the prostate: improved robustness with stretched exponential modelingYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Comput Assist Tomogr 36:695-703. 2012..This study aimed to compare the intraclass correlation coefficients of parameters estimated with stretched exponential and biexponential diffusion models of in vivo diffusion-weighted magnetic resonance imaging (MRI) of the prostate...
MRI of the prostate: clinical relevance and emerging applicationsYousef Mazaheri
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
J Magn Reson Imaging 33:258-74. 2011....
1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterizationKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, NY, USA
Cancer Biomark 4:263-76. 2008..This article reviews the assessment of choline-containing compounds, citrate, and polyamines as markers for prostate tumor detection and aggressiveness...
Motion correction of multi-b-value diffusion-weighted imaging in the liverYousef Mazaheri
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Acad Radiol 19:1573-80. 2012..The objective of this article is to present a reliable method to reduce motion-related artifacts during free-breathing at higher b-values when signal levels are low...
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomyMichael H Fuchsjäger
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
BJU Int 104:315-20. 2009..To investigate whether magnetic resonance imaging (MRI) findings, when converted into a scoring system, can predict the biochemical recurrence of prostate cancer after radical prostatectomy (RP)...
Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopyKristen L Zakian
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 63:9042-7. 2003..The results are promising, although a prospective study is necessary for confirmation. (31)P MRSI appears to be a useful tool for the prediction of survival before therapy in bone sarcomas...
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intentIman Osman
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 20:2980-7. 2002..Prospective and larger studies are necessary before integration of these molecular markers as part of molecular staging and predictors for organ preservation or other outcomes...
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a (1) H MRS studyJing Qi
Memorial Sloan Kettering Cancer Center, New York, NY, USA
NMR Biomed 26:204-12. 2013..Six of 26 patients developed steatosis during chemotherapy. Lipid changes were observable at 6 weeks. Copyright © 2012 John Wiley & Sons, Ltd...
MR imaging of the prostate in clinical practiceYousef Mazaheri
Departments of Medical Physics and Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
MAGMA 21:379-92. 2008..This review summarizes the role of MR imaging in the management of prostate cancer and describes practical approaches to implementing anatomic, metabolic and functional MR imaging techniques in the clinic...
The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancerMichael Fuchsjager
Department of Radiology, Medical University of Vienna, Vienna, Austria, and Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Clin Adv Hematol Oncol 7:193-202. 2009..This review will provide a brief overview of MRI techniques relevant to prostate cancer, including MR spectroscopic imaging, and discuss the ways that they can aid in diagnosis, treatment selection, and post-treatment follow-up...
Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methodsMing-Lan Lu
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Clin Cancer Res 8:171-9. 2002..015), and it appears to be a significant prognostic factor associated with patient survival...
Improved prediction of prostate cancer recurrence through systems pathologyCarlos Cordon Cardo
Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Invest 117:1876-83. 2007..This robust platform has broad applications in patient diagnosis, treatment management, and prognostication...
31P MR spectroscopic imaging detects regenerative changes in human liver stimulated by portal vein embolizationJing Qi
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Magn Reson Imaging 34:336-44. 2011..Second, to compare the biophysiologic differences between hepatic regeneration stimulated by PVE and by partial hepatectomy (PH)...
Comparison of gene expression profiles in laser-microdissected, nonembedded, and OCT-embedded tumor samples by oligonucleotide microarray analysisMarta Sanchez-Carbayo
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Clin Chem 49:2096-100. 2003
Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcomeMarta Sanchez-Carbayo
Division of Molecular Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY 10021, USA
Oncogene 22:5298-305. 2003..Nuclear myopodin expression in the context of cell-cycle progression may prove useful for staging bladder tumors and suggest a tumor suppressor role of myopodin in bladder cancer...
The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147Marc Ladanyi
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 160:1215-21. 2002..The possible basis for the overproduction or impaired surface localization of these proteins in ASPS remains unclear...
Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarraysAxel Hoos
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Am J Pathol 160:175-83. 2002..Molecular alterations in the p53 pathway play a role in Hürthle cell tumorigenesis, but other unidentified molecular changes seem to be required to induce the malignant phenotype...
Methylthioadenosine phosphorylase gene deletions are common in osteosarcomaJosé M García-Castellano
Orthopaedic Surgery Service, affiliated with Weil Medical College of Cornell University, New York, NY 10021, USA
Clin Cancer Res 8:782-7. 2002..The aim of this study was to investigate the frequency of molecular alterations in MTAP in osteosarcoma...
p27 as a target for cancer therapeuticsStacy W Blain
Department of Cell Biology and Genetics, Memorial Sloan-Kettering Cancer Institute, 1275 York Avenue, New York, NY 10021, USA
Cancer Cell 3:111-5. 2003
Research Grants
- MR Dynamic Imaging and Spectroscopy in Head & Neck CancersAMITA DAVE; Fiscal Year: 2007..If successful, it will provide an a priori predictor of failure/response to chemotherapy and/or long term disease free-survival, resulting in patient specific treatment which will likely enhance outcome. ..
- MR Dynamic Imaging and Spectroscopy in Head & Neck CancersAMITA DAVE; Fiscal Year: 2010..If successful, it will provide an a priori predictor of failure/response to chemotherapy and/or long term disease free-survival, resulting in patient specific treatment which will likely enhance outcome. ..
